国产成人嫩模一区二区|超级黄色网页|兔子先生tz|麻豆文化传媒网站官网污|在线播放欧美日韩精品|爱豆影视传媒免费下载|蜜桃影像传媒av剧情|麻豆文化传媒APP最新iOS|陈可心倩女幽魂爱豆传媒|91国视频产,国产传媒播放,想看三级片,网红吃瓜黑料爆料网反差

Research Interests

• Acute myeloid leukemia (AML) accounts for 80% of adult acute leukemia, with the median age at diagnosis of 68 years. Chemotherapy has been the main therapeutic strategy for AML patients with poor prognosis in elderly patients (age 60 years and older). Differentiation therapy with relatively less severe side effects may benefit for elderly patients. However, all-trans retinoic acid (ATRA), a hallmark of successful differentiation therapy, is only effective in acute promyelocytic leukemia (APL), but not other subtype of AML. Therefore, we focus on discovering strategies to sensitize non-APL AML cells to ATRA and developing ATRA-based treatments for non-APL AML patients.